메뉴 건너뛰기




Volumn 106, Issue 3, 2010, Pages 162-167

Predicting drug disposition via application of a biopharmaceutics drug disposition classification system

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CARRIER PROTEIN; CEFADROXIL; CEFRADINE; CYTOCHROME P450 3A; FEXOFENADINE; GEMCITABINE; GLYCOPROTEIN P; LEVOFLOXACIN; LORACARBEF; OFLOXACIN; PREGABALIN; ROSUVASTATIN; SOTALOL; TELMISARTAN;

EID: 77149165406     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2009.00498.x     Document Type: Conference Paper
Times cited : (90)

References (28)
  • 1
    • 0026457407 scopus 로고
    • Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction
    • Hebert MF, Roberts JP, Prueksaritanont T, Benet LZ. Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction. Clin Pharmacol Ther 1992 52 : 453 457.
    • (1992) Clin Pharmacol Ther , vol.52 , pp. 453-457
    • Hebert, M.F.1    Roberts, J.P.2    Prueksaritanont, T.3    Benet, L.Z.4
  • 3
    • 0028820208 scopus 로고
    • Differentiation of absorption and first-pass gut and hepatic metabolism in humans: Studies with cyclosporine
    • Wu C-Y, Benet LZ, Hebert MF, Gupta SK, Rowland M, Gomez DY et al. Differentiation of absorption and first-pass gut and hepatic metabolism in humans: studies with cyclosporine. Clin Pharmacol Ther 1995 58 : 492 497.
    • (1995) Clin Pharmacol Ther , vol.58 , pp. 492-497
    • Wu, C.-Y.1    Benet, L.Z.2    Hebert, M.F.3    Gupta, S.K.4    Rowland, M.5    Gomez, D.Y.6
  • 7
    • 17644380257 scopus 로고    scopus 로고
    • Predicting drug disposition via application of BCS: Transport/absorption/ elimination interplay and development of a Biopharmaceutics Drug Disposition Classification System
    • Wu C-Y, Benet LZ. Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a Biopharmaceutics Drug Disposition Classification System. Pharm Res 2005 22 : 11 23.
    • (2005) Pharm Res , vol.22 , pp. 11-23
    • Wu, C.-Y.1    Benet, L.Z.2
  • 8
    • 0028948839 scopus 로고
    • A theoretical basis for a biopharmaceutics drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability
    • Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutics drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995 12 : 413 420.
    • (1995) Pharm Res , vol.12 , pp. 413-420
    • Amidon, G.L.1    Lennernäs, H.2    Shah, V.P.3    Crison, J.R.4
  • 10
    • 62649128592 scopus 로고    scopus 로고
    • The use of drug metabolism for prediction of intestinal permeability (dagger)
    • Chen ML, Yu L. The use of drug metabolism for prediction of intestinal permeability (dagger). Mol Pharmaceut 2009 6 : 74 81.
    • (2009) Mol Pharmaceut , vol.6 , pp. 74-81
    • Chen, M.L.1    Yu, L.2
  • 11
    • 77149132279 scopus 로고    scopus 로고
    • Use of drug metabolism and Caco-2 transport for prediction of intestinal permeability revisited using accepted scientific definitions vs. an FDA surrogate
    • In press).
    • Larregieu CA, Benet LZ. Use of drug metabolism and Caco-2 transport for prediction of intestinal permeability revisited using accepted scientific definitions vs. an FDA surrogate. Mol Pharmaceut 2009 In press).
    • (2009) Mol Pharmaceut
    • Larregieu, C.A.1    Benet, L.Z.2
  • 13
    • 67649932264 scopus 로고    scopus 로고
    • European Medicines Agency. CPMP/WEP/QWP/1401/98. European Medicines Agency Web site (July 2008). 2008: Retrieved from
    • European Medicines Agency. Guideline on the investigation of bioequivalence. CPMP/WEP/QWP/1401/98. European Medicines Agency Web site (July 2008). 2008: Retrieved from http://www.emea.europa.eu/pdfs/human/qwp/ 140198enrev1.pdf.
    • Guideline on the Investigation of Bioequivalence.
  • 14
    • 0035054725 scopus 로고    scopus 로고
    • The gut as a barrier to drug absorption
    • Zhang Y, Benet LZ. The gut as a barrier to drug absorption. Clin Pharmacokinet 2001 40 : 159 168.
    • (2001) Clin Pharmacokinet , vol.40 , pp. 159-168
    • Zhang, Y.1    Benet, L.Z.2
  • 15
    • 0142212163 scopus 로고    scopus 로고
    • Disposition of tacrolimus in isolated perfused rat liver: Influence of troleandomycin, cyclosporine, and GG918
    • Wu C-Y, Benet LZ. Disposition of tacrolimus in isolated perfused rat liver: influence of troleandomycin, cyclosporine, and GG918. Drug Metab Dispos 2003 31 : 1292 1295.
    • (2003) Drug Metab Dispos , vol.31 , pp. 1292-1295
    • Wu, C.-Y.1    Benet, L.Z.2
  • 16
    • 1342302110 scopus 로고    scopus 로고
    • Ex situ inhibition of hepatic uptake and efflux significantly changes metabolism: Hepatic enzyme-transporter interplay
    • Lau YY, Wu C-Y, Okochi H, Benet LZ. Ex situ inhibition of hepatic uptake and efflux significantly changes metabolism: hepatic enzyme-transporter interplay. J Pharmacol Exp Ther 2004 308 : 1040 1045.
    • (2004) J Pharmacol Exp Ther , vol.308 , pp. 1040-1045
    • Lau, Y.Y.1    Wu, C.-Y.2    Okochi, H.3    Benet, L.Z.4
  • 17
    • 0142106303 scopus 로고    scopus 로고
    • Transporter-enzyme interactions: Implications for predicting drug-drug interactions from in vitro data
    • Benet LZ, Cummins CL, Wu C-Y. Transporter-enzyme interactions: implications for predicting drug-drug interactions from in vitro data. Curr Drug Metab 2003 4 : 393 398.
    • (2003) Curr Drug Metab , vol.4 , pp. 393-398
    • Benet, L.Z.1    Cummins, C.L.2    Wu, C.-Y.3
  • 18
    • 0029028792 scopus 로고
    • Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: Implications for drug delivery and activity in cancer chemotherapy
    • Wacher VJ, Wu C-Y, Benet LZ. Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Mol Carcinog 1995 13 : 129 134.
    • (1995) Mol Carcinog , vol.13 , pp. 129-134
    • Wacher, V.J.1    Wu, C.-Y.2    Benet, L.Z.3
  • 19
    • 31144438802 scopus 로고    scopus 로고
    • Multiple transporters affect the disposition of atorvastatin and its two active hydroxy metabolites: Application of in vitro and ex situ systems
    • Lau YY, Okochi H, Huang Y, Benet LZ. Multiple transporters affect the disposition of atorvastatin and its two active hydroxy metabolites: application of in vitro and ex situ systems. J Pharmacol Exp Ther 2006 316 : 762 771.
    • (2006) J Pharmacol Exp Ther , vol.316 , pp. 762-771
    • Lau, Y.Y.1    Okochi, H.2    Huang, Y.3    Benet, L.Z.4
  • 20
    • 33745230031 scopus 로고    scopus 로고
    • Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: Relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism
    • Lau YY, Okochi H, Huang Y, Benet LZ. Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism. Drug Metab Dispos 2006 34 : 1175 1181.
    • (2006) Drug Metab Dispos , vol.34 , pp. 1175-1181
    • Lau, Y.Y.1    Okochi, H.2    Huang, Y.3    Benet, L.Z.4
  • 21
    • 33846571368 scopus 로고    scopus 로고
    • Effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers
    • Lau YY, Huang Y, Frassetto L, Benet LZ. Effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers. Clin Pharmacol Ther 2007 81 : 194 204.
    • (2007) Clin Pharmacol Ther , vol.81 , pp. 194-204
    • Lau, Y.Y.1    Huang, Y.2    Frassetto, L.3    Benet, L.Z.4
  • 22
    • 0032793959 scopus 로고    scopus 로고
    • OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine
    • Cvetkovic M, Leake B, Fromm MF, Wilkinson GR, Kim RB. OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. Drug Metab Dispos 1999 27 : 866 871.
    • (1999) Drug Metab Dispos , vol.27 , pp. 866-871
    • Cvetkovic, M.1    Leake, B.2    Fromm, M.F.3    Wilkinson, G.R.4    Kim, R.B.5
  • 23
    • 41549098278 scopus 로고    scopus 로고
    • Establishment of a set of double transfectants coexpressing organic anion transporting polypeptide 1B3 and hepatic efflux transporters for the characterization of the hepatobiliary transport of telmisartan acylglucuronide
    • Ishiguro N, Maeda K, Saito A, Kishimoto W, Matsushima S, Ebner T et al. Establishment of a set of double transfectants coexpressing organic anion transporting polypeptide 1B3 and hepatic efflux transporters for the characterization of the hepatobiliary transport of telmisartan acylglucuronide. Drug Metab Dispos 2008 36 : 796 805.
    • (2008) Drug Metab Dispos , vol.36 , pp. 796-805
    • Ishiguro, N.1    Maeda, K.2    Saito, A.3    Kishimoto, W.4    Matsushima, S.5    Ebner, T.6
  • 24
    • 52949104006 scopus 로고    scopus 로고
    • Involvement of multiple transporters in the hepatobiliary transport of rosuvastatin
    • Kitamura S, Maeda K, Wang Y, Sugiyama Y. Involvement of multiple transporters in the hepatobiliary transport of rosuvastatin. Drug Metab Dispos 2008 36 : 2014 2023.
    • (2008) Drug Metab Dispos , vol.36 , pp. 2014-2023
    • Kitamura, S.1    Maeda, K.2    Wang, Y.3    Sugiyama, Y.4
  • 25
    • 0031662109 scopus 로고    scopus 로고
    • 5′-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter
    • Han H, de Vrueh RL, Rhie JK, Covitz KM, Smith PL, Lee CP et al. 5′-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter. Pharm Res 1998 15 : 1154 1159.
    • (1998) Pharm Res , vol.15 , pp. 1154-1159
    • Han, H.1    De Vrueh, R.L.2    Rhie, J.K.3    Covitz, K.M.4    Smith, P.L.5    Lee, C.P.6
  • 26
    • 23844467048 scopus 로고    scopus 로고
    • Amino acid ester prodrugs of the anticancer agent gemcitabine: Synthesis, bioconversion, metabolic bioevasion, and hPEPT1-mediated transport
    • Song X, Lorenzi PL, Landowski CP, Vig BS, Hilfinger JM, Amidon GL. Amino acid ester prodrugs of the anticancer agent gemcitabine: synthesis, bioconversion, metabolic bioevasion, and hPEPT1-mediated transport. Mol Pharmaceut 2005 2 : 157 167.
    • (2005) Mol Pharmaceut , vol.2 , pp. 157-167
    • Song, X.1    Lorenzi, P.L.2    Landowski, C.P.3    Vig, B.S.4    Hilfinger, J.M.5    Amidon, G.L.6
  • 27
    • 68149170038 scopus 로고    scopus 로고
    • The role of transporters in the pharmacokinetics of orally administered drugs
    • Shugarts S, Benet LZ. The role of transporters in the pharmacokinetics of orally administered drugs. Pharm Res 2009 26 : 2039 2054.
    • (2009) Pharm Res , vol.26 , pp. 2039-2054
    • Shugarts, S.1    Benet, L.Z.2
  • 28
    • 39149115065 scopus 로고    scopus 로고
    • Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption
    • Custodio JM, Wu C-Y, Benet LZ. Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption. Adv Drug Deliv Rev 2008 60 : 717 733.
    • (2008) Adv Drug Deliv Rev , vol.60 , pp. 717-733
    • Custodio, J.M.1    Wu, C.-Y.2    Benet, L.Z.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.